SCHEMBL20094544

SCHEMBL20094544

C=C(C)NC(=O)NC(C)C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.41
ALDH1A1 P00352 3/20 0.41
EPHX1 P07099 1/20 0.41
LMNA P02545 4/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
CA12 O43570 2/20 0.36
CA1 P00915 2/20 0.36
CA2 P00918 2/20 0.36
CA9 Q16790 2/20 0.36
MMP1 P03956 1/20 0.36
MMP2 P08253 1/20 0.36
MMP9 P14780 1/20 0.36
MMP8 P22894 1/20 0.36
EPHX2 P34913 1/20 0.35
PKM P14618 1/20 0.35
GAA P10253 2/20 0.33
POLB P06746 1/20 0.33
HSD17B10 Q99714 1/20 0.33
TP53 P04637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13567284 0.81 RXFP1 (0.40) TSHRALDH1A1EPHX1LMNAMEN1
SCHEMBL19315826 0.81 ALDH1A1 (0.44) TSHRALDH1A1EPHX1LMNAMEN1
SCHEMBL23994365 0.79 LMNA (0.46) TSHRALDH1A1EPHX1LMNAMEN1
SCHEMBL6448942 0.78 ALDH1A1 (0.38) TSHRALDH1A1LMNACA2HSD17B10
SCHEMBL27413217 0.75 TSHR (0.52) TSHRALDH1A1EPHX1LMNAMEN1
SCHEMBL23346590 0.75 EPHX1 (0.37) TSHRALDH1A1EPHX1LMNAMEN1
SCHEMBL27390051 0.75 EPHX1 (0.46) TSHRALDH1A1EPHX1LMNAMEN1
SCHEMBL745482 0.74 ALDH1A1 (0.54) TSHRALDH1A1EPHX1LMNAMEN1
SCHEMBL16314492 0.72 ALDH1A1 (0.39) TSHRALDH1A1EPHX1LMNAMEN1
SCHEMBL3071611 0.72 CRBN (0.43) TSHRALDH1A1EPHX1LMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018075842-A1 CONDENSED BENZODIAZEPINE DERIVATIVES AND CONJUGATES MADE THEREFROM BRISTOL-MYERS SQUIBB COMPANY (US) 2018-04-26 WO disclosed